Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
NCT01680575 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2017-05-31
Summary
To develop a robust prediction model to predict the occurrence of grade 3-4 neutropenia induced by adjuvant paclitaxel/carboplatin chemotherapy in patients with epithelial ovarian cancer and to validate this model.
Conditions
- Epithelial Ovarian Cancer
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Jeong-Yeol Park, M.D., Ph.D. · Asan Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2018-05-31
- Completion
- 2018-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
NCT01650376 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
NCT00191646 ·Status: COMPLETED ·Phase: PHASE3
-
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
NCT00369954 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
NCT01506856 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT01219777 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
NCT01851746 ·Status: UNKNOWN
-
Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer
NCT00886717 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
NCT00003998 ·Status: COMPLETED ·Phase: PHASE3
-
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
NCT05276973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
NCT01616303 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer
NCT02344095 ·Status: COMPLETED ·Phase: PHASE1
-
Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
NCT00452985 ·Status: COMPLETED
-
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
NCT03019315 ·Status: UNKNOWN
-
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
NCT04337632 ·Status: UNKNOWN ·Phase: PHASE3
-
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
NCT00189371 ·Status: TERMINATED ·Phase: PHASE3
-
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer
NCT00102414 ·Status: COMPLETED ·Phase: PHASE3
-
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
NCT00189579 ·Status: TERMINATED ·Phase: PHASE2
-
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
NCT00316407 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
NCT00006453 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)
NCT01357161 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer
NCT04561817 ·Status: WITHDRAWN ·Phase: PHASE2
-
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
NCT00390611 ·Status: COMPLETED ·Phase: PHASE2
-
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
NCT02035345 ·Status: TERMINATED ·Phase: PHASE4